Iontophoresis
is a technique, which uses an electric current to deliver a medicine
or other chemicals through the skin. Iontophoresis is often suggested
for people with hyperhidrosis (excessive sweating) of the hands
and/or feet as it aids in reducing sweating. Iontophoresis is
suitable for applications such as acetic acid (calcific tendinitis),
calcium chloride and magnesium sulfate (control of musculoskeletal
spasms), dexamethasone (inflammation), lidocaine (inflammation of
soft tissues), and zinc oxide (rheumatoid arthritis).
Get
In-Depth Sample Copy @
https://www.coherentmarketinsights.com/insight/request-sample/2248
Medicine
Iontophoresis Market Drivers
Increasing
awareness for treatment of hyperhidrosis is expected to drive growth
of the medicine iontophoresis market. For instance, in the U.S., the
International Hyperhidrosis Society (IHhS) IHhS celebrates the month
of November as Hyperhidrosis Awareness Month by making documentaries,
conducting interviews of patients, and organizing various events to
raise awareness of hyperhidrosis among the populace. Moreover,
increasing research on iontophoresis in treating various diseases and
symptoms is expected to boost growth of the medicine iontophoresis
market. For instance, in April 2018, EyeGate Pharma Company developed
a novel ocular drug delivery system called EyeGate II iontophoresis,
where an electric current generated in the device delivers ionized
drug into the eye and further gets absorbed into the eye by the
electric current.
Medicine
Iontophoresis Market Restraints
Side
effects and the limitations associated with medicine iontophoresis
therapy are expected to restrain medicine iontophoresis market
growth. For instance, according to British Association of
Dermatologists 2016 report, people often complain symptoms of
bruising or blisters incase the intensity of current is too high for
iontophoresis, a sensation of mild burning in case the electrode is
touched, and itchiness in the treated area after treatment. Moreover,
patients with cardiac pacemakers or with metal implants are not
suitable for iontophoresis treatment.
Medicine
Iontophoresis Market – Regional Analysis
On
the basis of region, the global medicine iontophoresis market is
segmented into North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa.
North
America is projected to hold dominant position in the global medicine
iontophoresis market due to insurance and reimbursement strategies
for treating hyperhidrosis patients. For instance, in the U.S.,
International Hyperhidrosis Society offers useful tools, information,
and downloadable forms related to the insurance and reimbursement
process. This comprises health plans for hyperhidrosis treatments,
cost of therapy, medical insurance form for purchasing iontophoresis
devices, and others. Such insurance and reimbursement services allow
efficient treatment of hyperhidrosis.
Medicine
Iontophoresis Market Competitor Analysis
Key
players operating in the global medicine iontophoresis market
include, ORGANIX GmbH & Co. KG, Hidrex USA, Drionic, IOMED, R.A.
Fischer, Iskra Medical d.o.o., Chattanooga, Encore Medical, L.P.,
iTech Medical, Inc., Kimetec GmbH, and AAM.
Medicine
Iontophoresis Market – Taxonomy
By Product
Type:
-
High Frequency Devices
-
Low Frequency Devices
By Modality:
-
Tabletop
-
Portable
By End User:
-
Hospitals
-
Clinics
-
Home
-
Others
By Region:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East
-
Africa
Request
For Customization @
https://www.coherentmarketinsights.com/insight/request-customization/2248
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment